Matthew Nicoletti is a visionary executive and strategic leader with more than 15 years of distinguished experience driving transformative growth across healthcare, technology, finance, and real estate. He has led high impact capital raising campaigns in the health sciences, executed complex mergers and acquisitions, guided successful public listings, and delivered substantial EBITDA growth along with significant improvements in operational efficiency. He has built high level partnerships with Fortune 500 companies and premier global institutions, generating substantial value creation in technology, healthcare, and consumer sectors.
Mr. Nicoletti serves as Chief Strategy Officer and Director at Perpetuals.com, where he spearheads high stakes strategic initiatives, capital markets expansion, and the integration of cutting edge AI powered fintech solutions to capture opportunities in the multi trillion dollar global derivatives market. In parallel, he serves as Senior Scientist of Health Finance at McMaster University, where he collaborates with leading faculty on interdisciplinary research, has conducted high level financing evaluations across sub Saharan Africa and South America, and plays an active role on the Clinical Trial Committee of the landmark TOGETHER trial, an international adaptive platform study recognized with the prestigious 2021 David Sackett Clinical Trial of the Year award by the Society for Clinical Trials. He also serves as an Advisor to the Global Burden of Disease study at the Institute for Health Metrics and Evaluation (IHME), University of Washington.
Mr. Nicoletti also serves on the Advisory Board and serves as Senior Strategic Advisor for ViRx at Stanford University. In this role, he drives financing strategies and major funding initiatives to accelerate the development of broad spectrum antivirals and the groundbreaking BioShield platform. He supports the advancement of key projects, cultivates high level institutional and global partnerships, refines strategic priorities, and spearheads expansion efforts aimed at building proactive antiviral defenses against future pandemics through interdisciplinary collaboration, AI integration, and translational research.
A visionary entrepreneur and philanthropist, Mr. Nicoletti’s pioneering work at the intersection of health finance, economics, data science, capital strategy, and global biosecurity bridges rigorous academic inquiry with real world impact. His contributions continue to shape sustainable investment frameworks, policy innovation, and resilient healthcare and economic systems on a global scale.